Viewing Study NCT05547503


Ignite Creation Date: 2025-12-24 @ 7:36 PM
Ignite Modification Date: 2026-01-05 @ 2:35 AM
Study NCT ID: NCT05547503
Status: COMPLETED
Last Update Posted: 2025-10-21
First Post: 2022-09-14
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase I Single Ascending Dose and Multiple Ascending Doses of Oral AFA-281 in Healthy Volunteers
Sponsor: Afasci Inc
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: AFA-281-001
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View